MetLife financials
$95.20−0.65%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $77.08B | $70.99B | $66.91B | $68.77B | $68.70B | $67.84B | $69.62B | $67.94B | $62.31B | $60.79B |
| Gross profit | $27.37B | $26.26B | $22.32B | $19.26B | $25.58B | $26.38B | $28.16B | $25.29B | $24.00B | $24.43B |
| Gross margin | 35.5% | 37.0% | 33.4% | 28.0% | 37.2% | 38.9% | 40.4% | 37.2% | 38.5% | 40.2% |
| Operating income | $4.66B | $5.62B | $2.16B | $6.36B | $8.52B | $6.93B | $6.79B | $6.31B | $3.54B | $4.28B |
| Net income | $3.17B | $4.23B | $1.38B | $5.10B | $6.65B | $5.19B | $5.72B | $4.98B | $3.91B | $747.0M |
| Net margin | 4.1% | 6.0% | 2.1% | 7.4% | 9.7% | 7.7% | 8.2% | 7.3% | 6.3% | 1.2% |
| Diluted EPS | $4.71 | $5.94 | $1.81 | $6.30 | $7.65 | $5.68 | $6.06 | $4.91 | $3.62 | $0.67 |
| EBITDA | $2.92B | $3.51B | $509.0M | $2.48B | $6.93B | $6.73B | $6.43B | $5.92B | $3.29B | $3.82B |
| Operating cash flow | $17.09B | $14.60B | $13.72B | $13.04B | $12.35B | $11.64B | $13.79B | $11.74B | $12.28B | $14.77B |
| Free cash flow | $17.09B | $14.60B | $13.72B | $13.04B | $12.35B | — | — | — | — | — |
| Diluted shares | 673.3M | 711.1M | 762.3M | 808.9M | 869.4M | 913.2M | 944.4M | 1,013.9M | 1,078.5M | 1,108.5M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $22.03B | $20.07B | $20.64B | $20.20B | $20.05B | $19.80B |
| Short-term investments | $151.93B | $139.50B | $144.63B | $146.04B | $179.87B | $199.97B |
| Total debt | $20.54B | $19.19B | $19.46B | $18.70B | $50.12B | $48.47B |
| Total assets | $745.17B | $677.46B | $687.58B | $663.07B | $759.71B | $795.15B |
| Total liabilities | $716.25B | $649.75B | $657.33B | $632.95B | $691.96B | $720.33B |
| Shareholders' equity | $28.68B | $27.70B | $30.25B | $30.13B | $67.75B | $74.82B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology